FTMH closure was observed in a greater proportion of ocriplasmin - vs vehicle-injected patients with baseline FTMH width 250 m ( 58.3 % vs 16.0 % , P < .001 ) and > 250 to 400 m ( 36.8 % vs 5.3 % , P = .009 ) .